Related references
Note: Only part of the references are listed.Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria
Ramin Mazhari et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Carolyn M. Nielsen et al.
JCI INSIGHT (2023)
Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine
Myriam Arevalo-Herrera et al.
NATURE COMMUNICATIONS (2022)
Prevalence and risk of Plasmodium vivax infection among Duffy-negative individuals: a systematic review and meta-analysis
Polrat Wilairatana et al.
SCIENTIFIC REPORTS (2022)
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Rebecca P. Payne et al.
CELL (2021)
Controlled human malaria infection with a clone of Plasmodium vivax with high- quality genome assembly
Angela M. Minassian et al.
JCI INSIGHT (2021)
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Amy Flaxman et al.
LANCET (2021)
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M. Minassian et al.
MED (2021)
Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity
Jean Popovici et al.
NATURE COMMUNICATIONS (2020)
Plasmodium vivax in the Era of the Shrinking P. falciparum Map
Ric N. Price et al.
TRENDS IN PARASITOLOGY (2020)
Global distribution of single amino acid polymorphisms inPlasmodium vivaxDuffy-binding-like domain and implications for vaccine development efforts
Payal Mittal et al.
OPEN BIOLOGY (2020)
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody
Thomas A. Rawlinson et al.
NATURE MICROBIOLOGY (2019)
Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research
Franziska Mohring et al.
ELIFE (2019)
Malaria Vaccines: Recent Advances and New Horizons
Simon J. Draper et al.
CELL HOST & MICROBE (2018)
Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes
Caroline Junqueira et al.
NATURE MEDICINE (2018)
Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax
Sonal Gupta et al.
SCIENTIFIC REPORTS (2018)
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
Kavita Singh et al.
NPJ VACCINES (2018)
Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
Camila Tenorio Franca et al.
ELIFE (2017)
An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
Francis B. Ntumngia et al.
SCIENTIFIC REPORTS (2017)
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Ruth O. Payne et al.
JCI INSIGHT (2017)
Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians
Vanessa C. Nicolete et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth O. Payne et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
Jason A. Regules et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Jason W. Bennett et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC
Joseph D. Batchelor et al.
PLOS PATHOGENS (2014)
Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection
Alexander D. Douglas et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy Volunteers
James S. McCarthy et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Fya/Fyb antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria
Christopher L. King et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean Children
Jennifer L. Cole-Tobian et al.
INFECTION AND IMMUNITY (2009)
Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection
Christopher L. King et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phase 1 clinical trial of apical membrane antigen 1:: an asexual blood-stage vaccine for Plasmodium falciparum malaria
EM Malkin et al.
INFECTION AND IMMUNITY (2005)